Last updated on June 2018

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia


Brief description of study

The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development of the fetus/infant at birth and for the first 2 years will also be followed.

Clinical Study Identifier: NCT02556775

Contact Investigators or Research Sites near you

Start Over

Fakultni nemocnice Kralovske Vinohrady
Praha 10, Czechia